Avicanna Inc.
AVCN.TOTSXHealthcare● Active
$0.12
+$0.00(+0.00%)
Market Cap$14466065
P/E Ratio—
52W High$0.31
52W Low$0.11
Avicanna Inc. (AVCN.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AVCN.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $25.48M | $25.46M | $16.79M | $4.05M | $3.27M |
| Cost of Revenue | $12.64M | $12.56M | $10.13M | $2.93M | $0.44M |
| Gross Profit | $12.84M | $12.90M | $6.66M | $1.11M | $2.83M |
| Gross Margin %(computed) | 50.41% | 50.66% | 39.66% | 27.54% | 86.63% |
| Operating Expenses | |||||
| R&D Expenses | $0.26M | $0.18M | $0.33M | $0.28M | $0.30M |
| G&A Expenses | $11.74M | $12.88M | $11.89M | $9.61M | $12.53M |
| Total Operating Expenses | $15.56M | $17.58M | $15.04M | $11.53M | $14.24M |
| Operating Income | ($2.72M) | ($4.68M) | ($7.93M) | ($10.41M) | ($11.41M) |
| Operating Margin %(computed) | -10.66% | -18.38% | -47.25% | -257.16% | -349.13% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.05M | $0.33M | $0.61M | $1.67M | $0.74M |
| Income Before Tax | ($2.76M) | ($3.62M) | ($8.74M) | ($14.73M) | ($16.76M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M |
| Net Income | ($2.84M) | ($3.62M) | ($8.74M) | ($14.73M) | ($16.77M) |
| Net Margin %(computed) | -11.16% | -14.21% | -52.07% | -364.01% | -513.15% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.04 | $-0.10 | $-0.25 | $-0.41 |
| Wtd Avg Shares | 114.72M | 100.03M | 84.71M | 59.17M | 41.28M |
| EBITDA | ($1.97M) | ($2.43M) | ($7.36M) | ($12.18M) | ($15.13M) |
| EBITDA Margin %(computed) | -7.74% | -9.54% | -43.80% | -300.79% | -462.80% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more Avicanna Inc. data
About Avicanna Inc. (AVCN.TO) Income Statement
Avicanna Inc. (AVCN.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AVCN.TO reported revenue of $0.03B, gross profit of $0.01B (gross margin 50.41%), and net income of ($0.00B) — a net profit margin of -11.16%.
Frequently asked questions
AVCN.TO · 4 questionsAvicanna Inc. (AVCN.TO) reported revenue of $0.03B for 2025, up 0.1% year-over-year.
AVCN.TO revenueAVCN.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08